Article Details

Optimizing BTK Inhibitor Therapy Across B-Cell Malignancies - Oncology Nurse Advisor

Retrieved on: 2025-08-08 13:34:19

Tags for this article:

Click the tags to see associated articles and topics

Optimizing BTK Inhibitor Therapy Across B-Cell Malignancies - Oncology Nurse Advisor. View article details on hiswai:

Excerpt

They recommend a high-dose therapy/autologous stem cell rescue (HDT/ASCR) treatment plus anti-CD20 monoclonal antibodies with or without covalent BTK ...

Article found on: www.oncologynurseadvisor.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo